ADHD medications (Stimulants and Non-Stimulants)
-
Efficacy of Stimulants for Preschool ADHD (Attention-Deficit/Hyperactivity Disorder)
In this Papers Podcast, Dr. Luisa Sugaya and Dr. Luis C. Farhat discuss their co-authored JCPP Advances Special Issue Research Review ‘Efficacy of stimulants for preschool attention-deficit/hyperactivity disorder: A systematic review and meta-analysis’. Luisa and Luis are co-first authors of this work.
Read more -
How effective is medication for ADHD symptoms in children with ASD?
Clinically significant attention-deficit/hyperactivity disorder (ADHD) symptoms are common and impairing in children with autism spectrum disorder (ASD).1 Moreover, ADHD is the most common co-occurring mental health diagnosis driving increased rates of medication use in children with ASD.
Read more -
Most cited CAMH paper #19 of 25: Young People’s Experience of ADHD and Stimulant Medication: A Qualitative Study for the NICE Guideline
Ilina Singh, Tim Kendall, Clare Taylor, Alex Mears, Chris Hollis, Martin Batty, Sinead Keenan.
Read more
Key Practitioner Message includes; Close friendships are important to young people with ADHD and are sometimes used to protect them from bullying and in other difficult situations. -
An Interview with ‘Mr ACAMH’ – Professor Eric Taylor
Professor Eric Taylor has been at the heart of ACAMH for over 50 years. We caught up with the past Chair of ACAMH, and editor of JCPP to discuss his career.
Read more -
Telephone support for parents in ADHD
Due to its high prevalence, treating ADHD can place a burden on services. Self-help and remote interventions could offer a way to deliver treatment at scale, if they’re effective.
Read more -
Controversies in ADHD
In order to view this content, you need to be an ACAMH member. Membership starts from just 11p a day. We hope you consider joining and being part of the advancement of child and adolescent mental health.Read moreCurrent members will need to be registered as a website user and log in, our guide to this simple process can be accessed here.
-
JCPP Editorial: Volume 58, Issue 06, June 2017
“The continuing contributions of MTA over nearly two decades to initial attention-deficit hyperactivity disorder pharmacotherapy and long-term clinical course” by Michael H. Bloch
Read more -
JCPP Editorial: Volume 58, Issue 03, March 2017
“Making clinical trials smarter (and more interesting)” by R. M. Pasco Fearon
Read more